Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus therapy in liver transplantation
2009-016176-78Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of everolimus in liver transplant (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoints: Patients requiring steroid therapy for biopsy-proven acute rejection and Graft loss or patient death. Started May 2010; status: active.
02
Drugs
everolimus
03
Conditions
liver transplant
Beyond the preview
Go deeper on 2009-016176-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016176-78.